Literature DB >> 7021676

How complement kills E. coli. II. The apparent two-hit nature of the lethal event.

S D Wright, R P Levine.   

Abstract

We have studied the nature of complement (C) action on red blood cells and E. coli with respect to the number of "hits" required for membrane damage. Our method of analysis involves adding various amounts of purified C7 or C8 to serum preparations immunochemically depleted of C7 or C8, respectively, in order to construct dose-response curves for the action of C's terminal complex. The shape of the dose-response curves reflects the single or multiple-hit nature of C action. Our method confirms that C acts on red cells by a 1-hit mechanism, whether measured by lysis or by the permeation of a small molecule. In contrast, we find with E. coli that C-mediated outer membrane damage, inner membrane damage, and killing all appear to require more than 1 hit. We have also discovered a property of E. coli that displays a nonlethal 1-hit response to C that is particularly useful in the analysis of multiple-hit dose-response curves. Simultaneous measurements of this single-hit phenomenon and the multiple-hit killing of E. coli allow us to make direct comparisons of the amount of C needed for each response. On the basis of the midpoints of the single and multiple-hit curves, C-mediated membrane damage and killing of E. coli appear to be a 2-hit process.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021676

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  Does complement kill E. coli by producing transmural pores?

Authors:  J Born; S Bhakdi
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.

Authors:  J R Dankert; A F Esser
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

4.  Serum resistance encoded by colicin V plasmids in Escherichia coli and its relationship to the plasmid transfer system.

Authors:  A M Nilius; D C Savage
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

Review 5.  Is the membrane attack complex of complement an enzyme?

Authors:  M D Boyle
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 6.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

7.  Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94.

Authors:  M M Binns; J Mayden; R P Levine
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.

Authors:  R M Hamadeh; G A Jarvis; U Galili; R E Mandrell; P Zhou; J M Griffiss
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

9.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.